EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $335,000 | -66.0% | 7,535 | -68.0% | 0.00% | -70.0% |
| Q1 2021 | $984,000 | -14.1% | 23,570 | -4.2% | 0.01% | -23.1% |
| Q4 2020 | $1,145,000 | +222.5% | 24,595 | +315.9% | 0.01% | +333.3% |
| Q4 2019 | $355,000 | +1.7% | 5,913 | -4.2% | 0.00% | 0.0% |
| Q3 2019 | $349,000 | -21.2% | 6,171 | -22.4% | 0.00% | 0.0% |
| Q2 2019 | $443,000 | +4.7% | 7,950 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $423,000 | +55.5% | 8,370 | +23.9% | 0.00% | +50.0% |
| Q4 2018 | $272,000 | -44.7% | 6,758 | -4.7% | 0.00% | -33.3% |
| Q3 2018 | $492,000 | -20.6% | 7,094 | -13.5% | 0.00% | -25.0% |
| Q2 2018 | $620,000 | +37.2% | 8,198 | -4.5% | 0.00% | 0.0% |
| Q1 2018 | $452,000 | +15.9% | 8,582 | +17.7% | 0.00% | +33.3% |
| Q4 2017 | $390,000 | -16.1% | 7,294 | -6.4% | 0.00% | 0.0% |
| Q3 2017 | $465,000 | -1.5% | 7,794 | +30.2% | 0.00% | 0.0% |
| Q2 2017 | $472,000 | -4.6% | 5,985 | +0.3% | 0.00% | 0.0% |
| Q1 2017 | $495,000 | -64.5% | 5,969 | -70.1% | 0.00% | -72.7% |
| Q3 2016 | $1,395,000 | +63.7% | 19,933 | -9.3% | 0.01% | +37.5% |
| Q2 2016 | $852,000 | – | 21,965 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |